COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

Man Injured in Scooter Crash at Byron and Rosecrans Street


Scooter, SUV Collide in San Diego Accident

San Diego, CA (September 13, 2020) – A man was injured in a scooter crash in San Diego. The accident occurred on the evening of September 13 at Byron and Rosecrans streets.

A 36-year-old man was riding an electric scooter when he drove through a red light at an intersection. He collided with a Volvo SUV driven by a 20-year-old woman. 

The man suffered life-threatening injuries, including facial fractures. He was taken to a local hospital. The Volvo driver remained at the accident scene. 

#San Diego

#92106


June 5, 2020

Construction Worker Injured in Accident at Site of Main Library

Man Hit in Head in Riverside Accident...


March 11, 2020

Baby Killed, 2 Injured in Head-on Crash on West Nordhoff Street

Woman Arrested for DUI, Murder in Fatal North Hills Accident ...


March 23, 2020

1 Killed in Crash at Brea Canyon and Tonner Canyon Roads

2 Vehicles Collide in Fatal Brea Accident ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.